Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. - Wikidata - wikimedia - TriplyDB

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

http://www.wikidata.org/entity/Q33151769

about

Propranolol blocks cardiac and neuronal voltage-gated sodium channels Genotype-phenotype correlation in long QT syndrome Genetics of inherited primary arrhythmia disorders Long-QT syndrome: from genetics to management Management of Patients with Long QT Syndrome Inherited ion channel diseases: a brief review Recent advances in genetic testing and counseling for inherited arrhythmias 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Pharmacologic Approach to Defective Protein Trafficking in the E637K-hERG Mutant with PD-118057 and Thapsigargin A 26-year-old woman with recurrent loss of consciousness.Gene-specific paradoxical QT responses during rapid eye movement sleep in women with congenital long QT syndrome Congenital long QT syndromes: clinical features, molecular genetics and genetic testing.Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome.Risk of death in the long QT syndrome when a sibling has died.Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy.Risk stratification in electrical cardiomyopathies.Mutation-specific risk in two genetic forms of type 3 long QT syndrome.Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management Trigger-specific risk factors and response to therapy in long QT syndrome type 2.Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome Pharmacological and non-pharmacological management of the congenital long QT syndrome: the rationale Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients.[Cardiac syncope : diagnosis and therapy].β-blockers protect against dispersion of repolarization during exercise in congenital long-QT syndrome type 1.Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome.Sentinel symptoms in patients with unexplained cardiac arrest: from the cardiac arrest survivors with preserved ejection fraction registry (CASPER).Successful elimination of significant arrhythmia burden with flecainide in an adolescent with long QT syndrome type 3.Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome Genetic testing of inherited arrhythmias.Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy.A case of Long QT syndrome type 3 aggravated by beta-blockers and alleviated by mexiletine: the role of epinephrine provocation test.Long QT syndrome: a Korean single center study.Genotype-specific risk stratification and management of patients with long QT syndrome.Effect of beta-blockers on QT dynamics in the long QT syndrome: measuring the benefit.Importance of QT interval in clinical practice.Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study Genotype-phenotype aspects of type 2 long QT syndrome.

P2860

Q21129289-40D7ECD8-EE46-4C22-B1D5-582758B7A9DF Q26771322-6352BAE7-4627-48B4-A0BE-8BEFD2CB5287 Q26783570-832B78F4-C5C1-4941-A248-76071A5BDEB9 Q26823298-4C51A8D3-A17E-4814-9AA2-35949818AA80 Q28070269-11D6EEB0-3DEE-446D-B1B3-C091EFA589BC Q28071914-A4FF62C1-363A-4F00-96AA-D20C2F4E807A Q28074154-2FF731FD-8A95-453F-B04E-61588DD5D381 Q28087002-D26D9ECC-7F88-45C8-9298-FF4F0AC088B4 Q28533988-CC54EFB2-978E-409F-A958-E5869A3213FB Q30460335-7840354E-F273-4BED-B704-C42693F3E3C1 Q30468343-418B1CCA-D091-49B7-B9FE-821944286472 Q33153847-86229718-6D8E-45F9-8650-2EB2273CE137 Q33156201-BD279E0A-B1AF-49E9-8B1B-551FDCD5E0C3 Q33156334-C165E480-5D08-4380-BB32-2CA5C132FA24 Q33157573-0088C4FA-5F2B-4F4F-B847-10A34C2668B6 Q33157716-92E9A343-A6BE-45B5-A0E6-1C736863DD3A Q33158278-88B0DCE6-161F-4E2E-A5C7-2220BAEA2E7C Q33158299-129C3005-FFB8-45C9-989F-1D49DF6C5425 Q33158481-8F8556A7-A792-40B7-ACBC-F0E09CC92DF1 Q33159219-D9B6B263-C860-4F0D-AA2B-28371A686990 Q33159731-C6B1EF26-E78B-4A4C-8AE8-B2B0DE09E146 Q33159820-86A5C58C-844A-4BCF-A480-AD8EE874707F Q33159880-52C8421A-576F-4CA3-AFA5-7EAEA65F253F Q33159994-DA993B1C-1E12-410A-9BEB-15EE323615F8 Q33160110-17D164AC-2787-4CA4-9009-CE60795B5C1F Q33160170-F5367617-5DF9-4620-8A54-F02D58009FCC Q33160503-A8BB1A72-FA2A-4FD2-ABDC-91531C357625 Q33160736-509D9BBF-F8CA-4BFF-A8AB-14063241AA5A Q33160912-DE8CBEAE-3DBA-4A16-A988-05F65A54D094 Q33161113-3D6BDE82-43A3-47A7-8403-17D6CB00FD50 Q33161560-D6A797DA-1523-47A2-BF78-0A1F9E914948 Q33161775-92401887-2332-42DD-AF74-FBBDE604ABD1 Q33162301-9655BA26-0877-439B-9873-215A58A5902F Q33163411-7AA20113-97D5-4325-94BC-29492BEBF9EA Q33163507-0C01ABA6-0ECD-43D3-98E3-DCD4418771E1 Q33164311-7939C112-5F82-4060-9B59-F18075E99928 Q33165222-1E94829F-23AC-4F32-A986-EAFE191B100D Q33166896-F7184EC6-ED30-484E-9679-6C6D182BC471 Q33167640-C81EE165-F382-4162-9A4F-993A15D06A8B Q33598557-B02C9C8A-DFB2-44E2-B8E0-5550A1EA969D

P2860

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

http://www.wikidata.org/entity/Q33151769

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Association of long QT syndrom ...... ts treated with beta-blockers.

@ast

Association of long QT syndrom ...... ts treated with beta-blockers.

@en

type

label

Association of long QT syndrom ...... ts treated with beta-blockers.

@ast

Association of long QT syndrom ...... ts treated with beta-blockers.

@en

prefLabel

Association of long QT syndrom ...... ts treated with beta-blockers.

@ast

Association of long QT syndrom ...... ts treated with beta-blockers.

@en

P1433

Q33151769-DC22AB76-430B-4958-8834-8C7DA3E5209D

P1476

Q33151769-BA7B6C33-ABD4-4D17-B17D-60809991EC06

P2093

Q33151769-090D9D5A-2710-4F10-86CF-0A86D42E84CD

Q33151769-1ABC201F-06DF-4F2F-93DA-2937608CC7B3

Q33151769-1B5A47E5-A936-46BF-9407-48358BD92AA6

Q33151769-4B269A44-03BD-4B90-995E-8D99CDC355D7

Q33151769-71646D9C-48C9-4079-918C-0470C3B9F1C5

Q33151769-A7263A6C-D6E9-41A3-AFB1-CB0424D2629D

Q33151769-AF8903A4-72EA-4C6A-92FC-BF14B8511FA9

P304

Q33151769-0971D260-DF17-45EB-A934-F915F28FE46E

P31

Q33151769-14E1B43D-E030-4C51-970F-361BC0829465

P356

Q33151769-91B12917-AD07-4019-A49C-6F09ECE40386

P407

Q33151769-7502AD0E-4889-46D9-A861-5B4FC416191A

P433

Q33151769-66F69F49-E49A-4E5B-9308-8215D6EC51E5

P478

Q33151769-4ADFF947-5829-44CB-BEC0-02EBBEAC74A3

P50

Q33151769-28094159-B0CE-4AAA-880E-167F5D024142

Q33151769-3378F477-7A55-40A7-AF13-4A3EC3ECBCE8

Q33151769-50858466-B187-4979-97A5-53D5E05A48BF

Q33151769-F5E962B9-5E78-4167-8897-A8752A79F9EA

P577

Q33151769-D1B422B1-BD21-4B4C-89C2-79D76565BD02

P5875

Q33151769-E039F312-CD90-4178-BE0B-1F4650CC6640

P698

Q33151769-9F7015FF-9B2F-481E-BDB2-89D91B5A0A5F

P356

JAMA.292.11.1341

P1433

Journal of the American Medical Association

P1476

Association of long QT syndrom ...... nts treated with beta-blockers

@en

P2093

Alessia Veia

http://www.w3.org/2001/XMLSchema#string

Chiara Tulipani

http://www.w3.org/2001/XMLSchema#string

Cinzia Moncalvo

http://www.w3.org/2001/XMLSchema#string

Elena Ronchetti

http://www.w3.org/2001/XMLSchema#string

Georgia Bottelli

http://www.w3.org/2001/XMLSchema#string

Massimiliano Grillo

http://www.w3.org/2001/XMLSchema#string

Raffaella Bloise

http://www.w3.org/2001/XMLSchema#string

P304

1341-1344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.292.11.1341

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

292

http://www.w3.org/2001/XMLSchema#string

P50

Peter J. Schwartz

Carlo Napolitano

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8346286

http://www.w3.org/2001/XMLSchema#string

P698

15367556

http://www.w3.org/2001/XMLSchema#string